Table 1.
Distribution of specific cancersa by provider type among AYAs 15 to 24 years old (CCR, 1999–2008).
| Total | Adult | Pediatric | Unknown | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | n | n | % b | % c | n | % b | % c | n | % b | % c |
| Total | 9,993 | 8,507 | 85.1 | — | 1,242 | 12.4 | — | 244 | 2.5 | — |
| Lymphoma | 2,633 | 2,302 | 87.4 | 27.1 | 278 | 10.6 | 22.4 | 53 | 2.0 | 21.7 |
| Hodgkin | 1,652 | 1,458 | 88.3 | 63.3 | 161 | 9.7 | 57.9 | 33 | 2.0 | 62.3 |
| Non–Hodgkin | 981 | 844 | 86.0 | 36.7 | 117 | 11.9 | 42.1 | 20 | 2.1 | 37.7 |
| Extracranial GCT | 2,111 | 1,969 | 93.3 | 23.1 | 87 | 4.1 | 7.0 | 55 | 2.6 | 22.5 |
| Gonadal | 1,958 | 1,833 | 93.6 | 93.1 | 73 | 3.7 | 83.9 | 52 | 2.7 | 94.5 |
| Non-gonadal | 153 | 136 | 88.9 | 6.9 | 14 | 9.1 | 13.8 | 3 | 2.0 | 5.5 |
| Sarcoma – soft tissue | 756 | 643 | 85.1 | 7.6 | 94 | 12.4 | 7.6 | 19 | 2.5 | 7.8 |
| Other | 337 | 291 | 86.3 | 45.2 | 38 | 11.3 | 40.4 | 8 | 2.4 | 42.1 |
| Fibromatous | 212 | 195 | 92.0 | 30.3 | 13 | 6.1 | 13.8 | 4 | 1.9 | 21.1 |
| Rhabdomyosarcoma | 113 | 81 | 71.7 | 12.6 | 27 | 23.9 | 28.7 | 5 | 4.4 | 26.3 |
| NOS | 94 | 76 | 80.9 | 11.8 | 16 | 17.0 | 17.0 | 2 | 2.1 | 10.5 |
| Sarcoma – bone | 632 | 455 | 72.0 | 5.3 | 163 | 25.8 | 13.1 | 14 | 2.2 | 5.7 |
| Osteosarcoma | 324 | 229 | 70.7 | 50.3 | 89 | 27.5 | 54.6 | 6 | 1.8 | 42.9 |
| Ewing sarcoma | 210 | 144 | 68.6 | 31.6 | 59 | 28.1 | 36.2 | 7 | 3.3 | 50.0 |
| Chondrosarcoma | 52 | 46 | 88.5 | 10.1 | 5 | 9.6 | 3.1 | 1 | 1.9 | 7.1 |
| NOS and other | 46 | 36 | 78.3 | 7.9 | 10 | 21.7 | 6.1 | — | — | — |
| Acute leukemia | 1,206 | 870 | 72.1 | 10.2 | 310 | 25.7 | 25.0 | 26 | 2.2 | 10.7 |
| Lymphoblastic | 761 | 518 | 68.1 | 59.5 | 224 | 43.2 | 72.3 | 19 | 3.7 | 73.1 |
| Myeloid | 445 | 352 | 79.1 | 40.5 | 86 | 19.3 | 27.7 | 7 | 1.6 | 26.9 |
| CNS malignancy | 1,041 | 831 | 79.8 | 9.8 | 176 | 16.9 | 14.2 | 34 | 3.3 | 13.9 |
| Low-grade astrocytoma | 240 | 186 | 77.5 | 22.4 | 45 | 18.7 | 25.6 | 9 | 3.8 | 26.5 |
| Glioma, other | 176 | 157 | 89.2 | 18.9 | 15 | 8.5 | 8.5 | 4 | 2.3 | 11.8 |
| High-grade astrocytoma | 162 | 132 | 81.5 | 15.9 | 23 | 14.2 | 13.1 | 7 | 4.3 | 20.6 |
| GCT | 124 | 90 | 72.6 | 10.8 | 31 | 25.0 | 17.6 | 3 | 2.4 | 8.8 |
| Astrocytoma, NOS | 112 | 85 | 75.9 | 10.2 | 22 | 19.6 | 12.5 | 5 | 4.5 | 14.7 |
| Medulloblastoma | 84 | 69 | 82.1 | 8.3 | 13 | 15.5 | 7.4 | 2 | 2.4 | 5.9 |
| Supratentorial PNET | 77 | 58 | 75.3 | 7.0 | 18 | 23.4 | 10.2 | 1 | 1.3 | 2.9 |
| Ependymoma | 66 | 54 | 81.9 | 6.5 | 9 | 13.6 | 5.1 | 3 | 4.5 | 8.8 |
| Carcinoma | 1,022 | 946 | 92.6 | 11.1 | 47 | 4.6 | 3.8 | 29 | 2.8 | 11.9 |
| Colorectal | 214 | 206 | 96.2 | 21.8 | 1 | 0.5 | 2.1 | 7 | 3.3 | 24.1 |
| Other, oropharynx | 158 | 151 | 95.5 | 16.0 | 4 | 2.6 | 8.5 | 3 | 1.9 | 10.3 |
| Breast | 134 | 132 | 98.6 | 14.0 | 1 | 0.7 | 2.1 | 1 | 0.7 | 3.4 |
| Lung | 81 | 69 | 85.2 | 7.3 | 8 | 9.9 | 17.0 | 4 | 4.9 | 13.8 |
| Liver/biliary | 72 | 55 | 76.4 | 5.8 | 15 | 20.8 | 31.9 | 2 | 2.8 | 6.9 |
| Renal cell | 70 | 67 | 95.8 | 7.1 | 2 | 2.8 | 4.2 | 1 | 1.4 | 3.4 |
| Nasopharyngeal | 67 | 58 | 86.5 | 6.1 | 5 | 7.5 | 10.6 | 4 | 6.0 | 13.8 |
| Other | 51 | 41 | 80.4 | 4.3 | 8 | 15.7 | 17.0 | 2 | 3.9 | 6.9 |
| Stomach | 44 | 43 | 97.7 | 4.5 | — | — | — | 1 | 2.3 | 3.4 |
| Pancreatic | 33 | 29 | 87.9 | 3.1 | 2 | 6.1 | 4.2 | 2 | 6.1 | 6.9 |
| Other, head/neck | 22 | 22 | 100.0 | 2.3 | — | — | — | — | — | — |
| Other, gastrointestinal | 20 | 20 | 100.0 | 2.1 | — | — | — | — | — | — |
| Other, genitourinary | 20 | 19 | 95.0 | 2.0 | — | — | — | 1 | 5.0 | 3.4 |
| Bladder | 15 | 15 | 100.0 | 1.6 | — | — | — | — | — | — |
| Adrenocortical | 14 | 12 | 85.7 | 1.3 | 1 | 7.1 | 2.1 | 1 | 7.1 | 3.4 |
| Gonadal, testicular | 7 | 7 | 100.0 | 0.7 | — | — | — | — | — | — |
| Other | 592 | 491 | 82.9 | 5.8 | 87 | 14.7 | 7.0 | 14 | 2.4 | 5.7 |
| Chronic myeloid leukemia | 175 | 141 | 80.6 | 28.7 | 27 | 15.4 | 31.0 | 7 | 4.0 | 50.0 |
| Neoplasms, other | 142 | 121 | 85.2 | 24.6 | 20 | 14.1 | 23.0 | 1 | 0.7 | 7.1 |
| Leukemia, NOS and other | 72 | 61 | 84.7 | 12.4 | 10 | 13.9 | 11.5 | 1 | 1.4 | 7.1 |
| Myeloma | 41 | 34 | 82.9 | 6.9 | 7 | 17.1 | 8.0 | — | — | — |
| Neoplasms, NOS | 36 | 35 | 97.2 | 7.1 | 1 | 2.8 | 1.1 | — | — | — |
| Intracranial/intraspinal, other | 31 | 26 | 83.9 | 5.3 | 4 | 12.9 | 4.6 | 1 | 3.2 | 7.1 |
| Paraganglioma and glomus | 23 | 18 | 78.3 | 3.7 | 3 | 13.0 | 3.4 | 2 | 8.7 | 14.2 |
| Gonadal, other | 20 | 17 | 85.0 | 3.5 | 2 | 10.0 | 2.3 | 1 | 5.0 | 7.1 |
| Other pediatric/embryonal | 18 | 11 | 61.1 | 2.2 | 6 | 33.3 | 6.9 | 1 | 5.6 | 7.1 |
| Neuroblastoma | 11 | 10 | 90.9 | 2.0 | 1 | 9.1 | 1.1 | — | — | — |
| Intracranial/intraspinal, NOS | 10 | 10 | 100.0 | 2.0 | — | — | — | — | — | — |
| Unclassified | 7 | 3 | 42.9 | 0.6 | 4 | 57.1 | 4.6 | — | — | — |
| Wilms | 6 | 4 | 66.7 | 0.8 | 2 | 33.3 | 2.3 | — | — | — |
Abbreviation: NOS, not otherwise specified.
aCancers excluded from analysis: melanoma, thyroid, cervical, endometrial, ovarian, and skin carcinoma, Kaposi sarcoma (see Methods).
bRow percentages (distribution between provider types).
cColumn percentages (distribution within provider type).